arrow
Back
S

Sun Young Rha

yonsei university college of medicine

86H-index
1.3KPaper Count
3.5WCitation Count
Published Papers 369
Publication Date
Safety and efficacy of ceralasertib, an ATR kinase inhibitor, combined with olaparib: dose escalation in advanced solid tumours and dose expansion in advanced breast cancer
err2026-09-30
err0
errOAAI
errJuanita S. Lopez; Seock-Ah Im; Sophie Postel-Vinay; Mario Campone; Anthony B. El-Khoueiry; Wassim Abida; Tobias Arkenau; Keun-Wook Lee; Sun Young Rha; Duncan I. Jodrell; Rebecca Roylance; Itziar Irurzun-Arana; Gemma N. Jones; Natalia Lukashchuk; Christine Stephens; Conor Norris; Arsène-Bienvenu Loembé; Emma Dean; Matthew G. Krebs
errShare
errSave
Evorpacept plus trastuzumab, ramucirumab and paclitaxel in HER2-positive gastric cancer: a randomized phase 2 trial
err2026-09-24
err0
errOAAI
errKohei Shitara; Zev Wainberg; Josep Tabernero; Eric Van Cutsem; Clélia Coutzac; Christelle De La Fouchardière; Jeeyun Lee; Sun Young Rha; Yoon-Koo Kang; Philip Fanning; Alison Forgie; Cherry Mao; Daniel Brickman; Jaume Pons; Athanasios C. Tsiatis; Sophia Randolph; Keun-Wook Lee
errShare
errSave
Digital intervention for medication adherence and symptom management, the SAFE for gastric cancer patients taking oral anticancer medication: A pilot feasibility study
err2026-09-23
err0
PREAI
errBomi Hong; Soo Hyun Kim; Kyunghwa Lee; Ji Hyun Sung; Sung-Hee Yoo; Eui Geum Oh; Sun Young Rha; Minkyu Jung; Jiyeon Lee
errShare
errSave
3 Safety Profile of Casdatifan Monotherapy in Patients with Clear Cell Renal Cell Carcinoma: Pooled Analysis of the ARC-20 Study (NCT05536141)
err2026-09-02
err0
errOAAI
errRana McKay; Jamie Merchan; Amita Patnaik; Alexandra Drakaki; Brian Rini; Sun Young Rha; Jae Lyun Lee; Moshe Ornstein; Rohit Kumar; Clara Hwang; Yusra Shao; Se Hoon Park; Pedro Barata; Bradley McGregor; Jianfen Chen; Melissa Eisen; Syed Quadri; Paul Foster; Toni Choueiri
errShare
errSave
Pembrolizumab plus chemotherapy as first-line therapy for advanced HER2-negative gastric or gastroesophageal junction adenocarcinoma: 4.5-year follow-up from the randomized phase III KEYNOTE-859 study
err2026-09-01
err0
PREAI
errRha, S. Y.; Wyrwicz, L. S.; Yanez, P.; Bai, Y.; Ryu, M-H; Lee, J.; Rivera, F.; Alves, G. Vasconcelos; Garrido, M.; Shiu, K-K; Fernandez, M. Gonzalez; Li, J.; Lowery, M. A.; Cil, T.; Cruz, F. Melo; Oh, D-Y; Wang, A.; Leconte, P.; Qin, S.
errShare
errSave
Lentinula edodes in Cancer Treatment: A Systematic Review and Meta-Analysis
err2026-08-26
err0
PREAI
errByeong Seok Sohn; In Sil Choi; Soo Young Kim; Young Il Kim; Chi Hoon Maeng; Youngduk Seo; Youn Ju Lee; Wonyoung Jung; Seok Jae Huh; Sun Young Rha; Jung Hye Kwon
errShare
errSave
Author Correction: Casdatifan shows durable response linked to HIF-2α biology in kidney cancer
errNature
IF48.5
err2026-08-04
err0
errOAAI
errToni K. Choueiri; Jaime Merchán; Amita Patnaik; Alexandra Drakaki; Brian I. Rini; Sun Young Rha; Jae Lyun Lee; Moshe C. Ornstein; Rohit Kumar; Clara Hwang; Yusra Shao; Se Hoon Park; Pedro C. Barata; Bradley A. McGregor; Paul Foster; Jianfen Chen; Melissa Eisen; Hunter Cole; Ben Weeder; Yinghui Guan; Jaskirat Singh; Angelo Kaplan; Soonweng Cho; Richard Markus; Omar Kabbarah; Rana R. McKay
errShare
errSave
Casdatifan shows durable response linked to HIF-2α biology in kidney cancer
errNature
IF48.5
err2026-07-01
err0
errOAAI
errToni K. Choueiri; Jamie Merchan; Amita Patnaik; Alexandra Drakaki; Brian I. Rini; Sun Young Rha; Jae Lyun Lee; Moshe C. Ornstein; Rohit Kumar; Clara Hwang; Yusra Shao; Se Hoon Park; Pedro C. Barata; Bradley A. McGregor; Paul Foster; Jianfen Chen; Melissa Eisen; Hunter Cole; Ben Weeder; Yinghui Guan; Jaskirat Singh; Angelo Kaplan; Soonweng Cho; Richard Markus; Omar Kabbarah; Rana R. McKay
errShare
errSave
Zanidatamab with and without Tislelizumab in HER2-Positive Gastroesophageal Cancer
err2026-05-28
err8
PREAI
errShitara, Kohei; Elimova, Elena; Liu, Tianshu; Tabernero, Josep; Lee, Keun-Wook; Schenker, Michael; Tebbutt, Niall C.; Ajani, Jaffer; Salimin, Norhidayu; Ku, Geoffrey; Gwang Kim, Jong; Ales Diaz, Inmaculada; Zhang, Jingdong; Pietrantonio, Filippo; Bai, Li-Yuan; Le Sourd, Samuel; Zhao, Jun; Hierro, Cinta; Kiberu, Andrew; Van Herpe, Filip; Bao, Yuanyuan; Zhang, Hanze; Yang, Lin; Li, Vincent; Gartner, Elaina M.; Chen, Ye; Grim, Jonathan; Rha, Sun Young; Shen, Lin
errShare
errSave
Clinicopathologic characteristics and genomic profiling of HER2-low advanced gastric or gastroesophageal junction cancer
err2026-05-13
err0
errOAAI
errC.K. Lee; D.H. Seo; S. Park; T. Yuh; Y. Kim; H. Park; J.S. Shim; H. Kim; H.S. Kim; M. Jung; H.C. Chung; S.Y. Rha
errShare
errSave
Molecular and Phenotypic Characterization of Fluid-Derived Patient-Derived Cell and Organoid Models in Advanced Gastric Cancer
err2026-04-01
err1
PREAI
errMoon, Ye Jin; Kwon, Woo Sun; Park, Chan Hee; Jang, Jinsoo; Park, Juin; Yoon, Byeong Gyu; Mun, Han Byeol; Kim, Namju; Lee, Choong-kun; Jeung, Hei Cheul; Shin, Su-Jin; Kim, Tae Soo; Rha, Sun Young
errShare
errSave
Lenvatinib plus Pembrolizumab for Patients with Previously Treated Advanced Gastric, Biliary Tract, or Pancreatic Cancer: Results from the Phase II LEAP-005 Study
err2026-03-01
err2
PREAI
errPonz-Sarvise, Mariano; Rha, Sun Young; Gomez-Roca, Carlos A.; Ortega Moran, Laura; Gill, Sanjeev; Tortora, Giampaolo; Geva, Ravit; Saada-Bouzid, Esma; Santoro, Armando; Kim, Tae Won; Heudobler, Daniel; Dutcus, Corina E.; Okpara, Chinyere E.; Ghori, Razi; Zhang, Yiwei; Vajdi, Amir; Dettman, E. J.; Jin, Fan; Groisberg, Roman; Shapira-Frommer, Ronnie
errShare
errSave
Domvanalimab and zimberelimab in advanced gastric, gastroesophageal junction or esophageal cancer: a phase 2 trial
err2025-10-18
err0
errOAAI
errYelena Y. Janjigian; Do-Youn Oh; Meredith Pelster; Zev A. Wainberg; Subhransu Prusty; Sandahl Nelson; Amy DuPage; Amy Thompson; Daniel O. Koralek; Edward Allan R. Sison; Sun Young Rha
errShare
errSave
Combination casdatifan plus cabozantinib in previously treated patients with clear cell renal cell carcinoma: results from an expansion cohort of ARC-20 (NCT05536141)
err2025-10-01
err0
errOAAI
errChoueri, Toni; Ornstein, Moshe; Barata, Pedro C.; Matrana, Marc; Merchan, Jaime; Gedye, Craig; Hwang, Clara; Kumar, Rohit; Lee, Jae Lyun; Guan, Yinghui; Ghasemi, Mohammad; Quadri, Syed; Negro, Chris; Chen, Jianfen; Foster, Paul; Warad, Deepti; McGregor, Bradley A.; Rha, Sun Young; Drakaki, Alexandra
errShare
errSave
Pembrolizumab with trastuzumab and chemotherapy for HER2-positive advanced gastric cancer: health-related quality-of-life analysis from the randomized KEYNOTE-811 trial
err2025-09-30
err0
errOAAI
errY.Y. Janjigian; A. Kawazoe; J. Xu; S. Lonardi; J.-P. Metges; L.S. Wyrwicz; L. Shen; Y. Ostapenko; M. Bilici; M.A. Lowery; A. Valderrama; Y. Guan; K. Li; C.-S. Shih; S.Y. Rha
errShare
errSave
First-line pembrolizumab plus chemotherapy for advanced HER2-negative gastric or gastroesophageal junction adenocarcinoma: Health-related quality of life from the randomized phase III KEYNOTE-859 trial
err2025-09-20
err0
PREAI
errMaeve A. Lowery; Lucjan S. Wyrwicz; Do-Youn Oh; Kai-Keen Shiu; Patricio Yañez; Yuxian Bai; Min-Hee Ryu; Jeeyun Lee; Fernando Rivera; Gustavo Vasconcelos Alves; Marcelo Garrido; Manuel González Fernández; Jin Li; Timuçin Çil; Felipe Melo Cruz; Shukui Qin; Yanfen Guan; Adriana Valderrama; Sonal Bordia; Sun Young Rha
errShare
errSave
Lenvatinib plus pembrolizumab for patients with previously treated select solid tumors: Results from the phase 2 LEAP-005 study recurrent glioblastoma cohort
errCancer
IF5.1
err2025-08-13
err0
errOAAI
errSun Young Rha MD, PhD; Eduardo Castanon MD; Sanjeev Gill MBBS, FRACP; Helene Senellart MD; Juanita Lopez MD, PhD; Iván Márquez-Rodas MD, PhD; Iván Victoria MD; Tae Min Kim MD, PhD; Zarnie Lwin MBBS, FCP, FRACP; Michael C. Burger MD; Matteo Simonelli MD; Philippe A. Cassier MD, PhD; Andrew E. Hendifar MD; Paolo A. Ascierto MD; Corina Dutcus MD; Chinyere E. Okpara PhD; Razi Ghori PhD; Fan Jin MD; Roman Groisberg MD; Luis Villanueva MD, MSc
errShare
errSave